Section Arrow
Quote
CUPR.NASDAQ
- Cuprina Holdings (Cayman) Limited
Quotes are at least 15-min delayed:2025/07/07 00:43 EDT
Last
 6.9
+0.22 (+3.29%)
Day High 
6.95 
Prev. Close
6.68 
1-M High
7.39 
Volume 
432.20K 
Bid
6.81
Ask
7.45
Day Low
6.6 
Open
6.75 
1-M Low
4.68 
Market Cap 
49.20M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 5.99 
20-SMA 5.77 
50-SMA 5.18 
52-W High 7.39 
52-W Low 3.51 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.07/--
Enterprise Value
49.36M
Balance Sheet
Book Value Per Share
-0.47
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
48.32K
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AVTRAvantor13.88-0.01-0.07%13.36PE
MBOTMicrobot Medical2.6+0.1+4.00%-- 
ALCAlcon87.78-1.52-1.70%39.69PE
XRAYDENTSPLY SIRONA16.67+0.1+0.60%-- 
COOCooper Companies (The)73.3+0.28+0.38%35.28PE
Quotes are at least 15-min delayed：2025/07/07 00:43 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.